Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 96
Filter
1.
Diabetes Metab Syndr ; 12(6): 839-842, 2018 Nov.
Article in English | MEDLINE | ID: mdl-28899639

ABSTRACT

BACKGROUND: It is being increasingly reported that some of the youth onset diabetes patients cannot be classified clearly as type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) based on usual criteria and the term double diabetes (DD) coined for these cases. AIM: The objective of the study was to find out the prevalence of DD in youth onset diabetes patients from east Delhi and neighboring NCR region. METHODS: A total of 200 patients with youth onset diabetes below 25 years of age were recruited from a tertiary care hospital in East Delhi. Clinical history, family history of diabetes and anthropometry of patients were recorded. Fasting serum C-peptide, Anti-IA2-antibody and Anti-GAD-antibody were measured in all patients. Patients positive for Anti-GAD-antibody (>1.05U/ml) and C-peptide level >0.3nmol/l were characterized as DD patients. Patients negative for Anti-GAD-antibody and C-peptide >0.3nmol/l were kept under the category of T2DM. Patients with low C-peptide level along with one of the following, positive Anti-GAD-antibody, positive Anti-IA2-antibody and diabetic ketoacidosis (DKA) were considered as T1DM. Remaining patients were kept under the unknown category. RESULTS: Mean age of study subjects was 18.2±7.1years. Seven percent (7%) of the subjects were classified as DD, 51% as T1DM, 13% as T2DM and 29% were kept under the unknown category. Mean age of subjects with 22.2±9.7, 16.9±6.7, 20.6±7.7 and 19.4±7.4 years in DD, T1DM, T2DM and unknown category respectively. Mean BMI of subjects with DD, T1DM, T2DM and unknown category was 19.8±5.7, 16.6±3.7, 19.3±4.1 and 18.0±4.6 kg/m2 respectively. CONCLUSION: Double diabetes is an important occurrence among youth onset diabetes subjects. Only half of the subjects with youth onset of diabetes had T1DM.


Subject(s)
Diabetes Mellitus, Type 1/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Adolescent , Age of Onset , Child , Female , Humans , India/epidemiology , Male , Prevalence , Young Adult
2.
Diabetes Metab Syndr ; 12(3): 313-316, 2018 May.
Article in English | MEDLINE | ID: mdl-29287842

ABSTRACT

AIM: To find out the prevalence of obesity and glucose intolerance among nurses working in tertiary care hospital. METHODS: Study was conducted in 496 apparently healthy females comprising two groups. Group B had 290 nurses and control group A had 206 age matched female subjects of general population. Detailed performa was filled which included anthropometry, systemic examination and other details. Fasting plasma glucose was done followed by oral glucose tolerance test (OGTT). Subjects with body mass index ≥23 kg/m2 were categorized as 'overweight' and ≥25 kg/m2 as 'obese' as per criteria for Asian Indians. Women with waist circumference of ≥80 cm were categorized as 'centrally obese'. RESULTS: Mean age of subjects in groups A and B was 40.45 ±â€¯8.64 years and 40.50 ±â€¯6.96 years respectively. Significantly higher number of nurses (80%) were overweight or obese compared to controls (59.71%,P = < .001). Similarly, central obesity was significantly higher in nurses (82.07%) compared to controls (67.96%,P = <.001). The prevalence of glucose intolerance (prediabetes and newly detected diabetes) was significantly higher in controls compared to nurses (45.63% vs 29.66%, P < .001). CONCLUSION: Every four out of five nurses working in tertiary care hospital have overweight/obesity and central obesity. Despite this they have lower rates of glucose intolerance.


Subject(s)
Biomarkers/analysis , Glucose Intolerance , Obesity/complications , Obesity/epidemiology , Prediabetic State/etiology , Tertiary Care Centers , Adult , Anthropometry , Blood Glucose/analysis , Body Mass Index , Case-Control Studies , Cross-Sectional Studies , Female , Follow-Up Studies , Glucose Tolerance Test , Glycated Hemoglobin/analysis , Humans , India/epidemiology , Nurses , Prevalence , Prognosis , Risk Factors
3.
Prog Mol Biol Transl Sci ; 142: 291-315, 2016.
Article in English | MEDLINE | ID: mdl-27571699

ABSTRACT

There is an urgent need to develop new vaccines for tuberculosis, HIV/AIDS, and malaria, as well as for chronic and debilitating infections known as neglected tropical diseases (NTDs). The term "NTD" emerged at the beginning of the new millennium to describe a set of diseases that are characterized as (1) poverty related, (2) endemic to the tropics and subtropics, (3) lacking public health attention and inadequate industrial investment, (4) having poor research funding and a weak research and development (R&D) pipeline, (5) usually associated with high morbidity but low mortality, and (6) often having no safe and long-lasting treatment available. Many additional challenges to the current control and elimination programs for NTDs exist. These include inconsistent performance of diagnostic tests, regional differences in access to treatment and in treatment outcome, lack of integrated surveillance and vector/intermediate host control, and impact of ecological climatic changes particularly in regions where new cases are increasing in previously nonendemic areas. Moreover, the development of NTD vaccines, including those for schistosomiasis, leishmaniasis, leprosy, hookworm, and Chagas disease are being led by nonprofit product development partnerships (PDPs) working in partnership with academic and industrial partners, contract research organizations, and in some instances vaccine manufacturers in developing countries. In this review, we emphasize global efforts to fuel the development of NTD vaccines, the translational activities needed to effectively move promising vaccine candidates to Phase-I clinical trials and some of the hurdles to ensuring their availability to people in the poorest countries of Africa, Asia, Latin America, and the Caribbean.


Subject(s)
Neglected Diseases/therapy , Translational Research, Biomedical , Tropical Medicine , Antigens/metabolism , Neglected Diseases/economics , Tropical Medicine/economics , Vaccines/immunology
4.
Trop Biomed ; 33(4): 652-662, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-33579061

ABSTRACT

The current epidemiological study was designed to trace the involved risk factors in Hepatitis C Virus (HCV) spread and to identify any association between HCV genotypes and risk factors. Blood samples were taken from 400 participants and viral genotyping was performed in order to find any possible relationship between the risk factors and genotypes. Major genotypes included 3, 1, 4 and several untypeable ones with prevalence rates 65%, 22.5%, 2.75% and 9.75% respectively. Surgery and dental procedure were strongly related to the spread of genotype 3b, while genotype 1b was strongly related to blood transfusion and dental procedures as a single combination risk factor. On the other hand genotypes 1a, 3a, 4 and the untypeable genotypes, were equally affected by all reported risk factors. The probability of occurrence of genotype 3a with reference to dental procedures was 11%. Dental procedures, unsafe injection and surgical procedures are the main risk factors while the blood transfusion in combination with dental procedures has emerged as a potent risk factor in the transmission of HCV.

5.
Clin Otolaryngol ; 40(6): 646-50, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25858299

ABSTRACT

OBJECTIVES: Poor camera control during endoscopic dacryocystorhinostomy (EnDCR) surgery can cause inadequate visualisation of the anatomy and suboptimal surgical outcomes. This study investigates the feasibility of using computer vision tracking in EnDCR surgery as a potential formative feedback tool for the quality of endoscope control. DESIGN: A prospective cohort analysis was undertaken comparing junior versus senior surgeons performing routine EnDCR surgery. Computer vision tracking was applied to endoscopic video footage of the surgery: Total number of movements, camera path length in pixels and surgical time were determined for each procedure. A Mann-Whitney U-test was used to test for a significant difference between juniors and seniors (P < 0.05). SETTING: Operating theatre. PARTICIPANTS: Ten junior surgeons (<20 completed procedures) and 10 senior surgeons (>100 completed procedures). MAIN OUTCOME MEASURES: Total number of movements of the endoscope per procedure. Path length of the endoscope per procedure. RESULTS: Twenty videos, 10 from junior surgeons and 10 from senior surgeons were analysed. Feasibility of our tracking system was demonstrated. Mean camera path lengths were significantly different at 119,329px (juniors) versus 43,697px (seniors), P ≪ 0.05. The mean number of movements was significantly different at 9134 (juniors) versus 3690 (seniors), P ≪ 0.05. These quantifiable differences demonstrate construct validity for computer vision endoscope tracking as a measure of surgical experience. CONCLUSIONS: Computer vision tracking is a potentially useful structured and objective feedback tool to assist trainees in improving endoscope control. It enables juniors to examine how their pattern of endoscope control differs from that of seniors, focusing in particular on sections where they are most divergent.


Subject(s)
Dacryocystorhinostomy/methods , Endoscopy/methods , Lacrimal Apparatus Diseases/surgery , Video Recording/instrumentation , Adolescent , Adult , Equipment Design , Female , Humans , Male , Operating Rooms , Prospective Studies , Reproducibility of Results , Young Adult
6.
Waste Manag ; 33(11): 2257-66, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23973052

ABSTRACT

Mechanical-biological treatment (MBT) processes are increasingly being adopted as a means of diverting biodegradable municipal waste (BMW) from landfill, for example to comply with the EU Landfill Directive. However, there is considerable uncertainty concerning the residual pollution potential of such wastes. This paper presents the results of laboratory experiments on two different MBT waste residues, carried out to investigate the remaining potential for the generation of greenhouse gases and the flushing of contaminants from these materials when landfilled. The potential for gas generation was found to be between 8% and 20% of that for raw MSW. Pretreatment of the waste reduced the potential for the release of organic carbon, ammoniacal nitrogen, and heavy metal contents into the leachate; and reduced the residual carbon remaining in the waste after final degradation from ∼320g/kg dry matter for raw MSW to between 183 and 195g/kg dry matter for the MBT wastes.


Subject(s)
Gases/analysis , Waste Management , Waste Products/analysis , Water Pollution/analysis , Biodegradation, Environmental , Calcium/analysis , Carbon/analysis , Chlorides/analysis , Fatty Acids, Volatile/analysis , Magnesium/analysis , Metals, Heavy/analysis , Nitrogen Compounds/analysis
7.
J Contam Hydrol ; 153: 106-21, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23726724

ABSTRACT

The effect of degradation and settlement on transport properties of mechanically and biologically treated (MBT) waste was examined by applying three different tracers to two waste columns (~0.5 m diameter) in a series of closed-loop experiments. One column was allowed to biodegrade and the other was bio-suppressed. Permeability and drainable porosity were reduced by settlement, in line with previous results. A dual-porosity model performed well against the data and suggested that more preferential flow occurred early on in the un-degraded column. Diffusion timescales were found to be between 0.8 and 6 days. Volumetric water contents of the mobile region were found to be small in the bio-suppressed cell (~0.01) and even smaller values were found in the degrading waste, possibly due to displacement by gas. Once either settlement or gas production had disrupted this pattern into a more even flow, subsequent compression made little difference to the diffusion time-scale. This may indicate that transport was thereafter dominated by other aspects of the waste structure such as the distribution of low-permeability objects. The presence of gas in the degrading waste reduced the volumetric water content through displacement. The model indicated that the gas was primarily located in the more mobile porosity fraction. Primary compression of the degrading waste tended to squeeze this gas out of the waste in preference to water.


Subject(s)
Models, Theoretical , Solid Waste , Waste Management/methods , Gases , Porosity , Water Pollutants, Chemical
8.
Waste Manag ; 32(7): 1420-6, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22513159

ABSTRACT

Mechanical-biological treatment of municipal solid waste has become popular throughout the UK and other parts of Europe to enable compliance with the Landfill Directive. Pretreatment will have a major influence on the degradation and settlement characteristics of the waste in landfills owing to the changes in the composition and properties of the wastes. This paper presents and compares the results of long term landfill behaviour of the UK and German MBT wastes pretreated to different standards. The gas generating potential, leachate quality and settlement characteristics are highlighted. The results reveal that it is possible to achieve stabilisation of MBT waste within a year and the biogas yield and leachate strength of German MBT waste was significantly reduced compared with the UK MBT waste. The settlement resulting from mechanical creep is more significant than the biodegradation induced settlement in both cases.


Subject(s)
Refuse Disposal/instrumentation , Refuse Disposal/methods , Water Pollutants, Chemical/chemistry , Biodegradation, Environmental , Biofuels , Equipment Design , Gases , Germany , Methane , United Kingdom
10.
Endoscopy ; 42(10): 790-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20886398

ABSTRACT

BACKGROUND AND STUDY AIMS: The impact of the diagnosis and treatment of dysplastic Barrett's esophagus on quality of life (QoL) is poorly understood. This study assessed the influence of dysplastic Barrett's esophagus on QoL and evaluated whether endoscopic treatment of dysplastic Barrett's esophagus with radiofrequency ablation (RFA) improves QoL. PATIENTS AND METHODS: We analyzed changes in QoL in the AIM Dysplasia Trial, a multicenter study of patients with dysplastic Barrett's esophagus who were randomly allocated to RFA therapy or a sham intervention. We developed a 10-item questionnaire to assess the influence of dysplastic Barrett's esophagus on QoL. The questionnaire was completed by patients at baseline and 12 months. RESULTS: 127 patients were randomized to RFA (n = 84) or sham (n = 43). At baseline, most patients reported worry about esophageal cancer (71 % RFA, 85 % sham) and esophagectomy (61 % RFA, 68 % sham). Patients also reported depression, impaired QoL, worry, stress, and dissatisfaction with the condition of their esophagus. Of those randomized, 117 patients completed the study to the 12-month end point. Compared with the sham group, patients treated with RFA had significantly less worry about esophageal cancer ( P=0.003) and esophagectomy ( P =0.009). They also had significantly reduced depression ( P=0.02), general worry about the condition of their esophagus ( P≤0.001), impact on daily QoL ( P=0.009), stress ( P=0.03), dissatisfaction with the condition of their esophagus ( P≤0.001), and impact on work and family life ( P=0.02). CONCLUSIONS: Inclusion in the treatment group of this randomized, sham-controlled trial of RFA was associated with improvement in disease-specific health-related quality of life. This improvement appears secondary to a perceived decrease in the risk of cancer.


Subject(s)
Barrett Esophagus/psychology , Barrett Esophagus/surgery , Catheter Ablation , Quality of Life/psychology , Aged , Anxiety/etiology , Chi-Square Distribution , Esophageal Neoplasms/prevention & control , Female , Humans , Male , Middle Aged , Precancerous Conditions/prevention & control , Statistics, Nonparametric , Surveys and Questionnaires
11.
Parasite Immunol ; 32(4): 252-8, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20398225

ABSTRACT

Although there is an effective drug (praziquantel) available for the treatment of schistosomiasis, yet the disease is still spreading unabated and is rampant in 76 countries. Control via praziquantel treatment has so far been insufficient in reducing the disease transmission. Therefore, a vaccine in addition to other strategies, for example, improving sanitation and introduction of new drugs are essential to successfully control and eventually eradicate schistosomiasis. To this effect, we have targeted a functionally important antigen, Sm-p80 as a vaccine candidate. In this study, full length cDNA of Sm-p80 was cloned in VR1020, a FDA approved vector for human use. The protective efficacy of this vaccine formulation was tested in a murine model. Sm-p80-VR1020 vaccine formulation was able to induce 47% reduction in worm burden. Serology on samples obtained from vaccinated animals revealed a strong antibody response which included IgG and all of its subtypes, IgM and IgA. Proliferating splenocytes in response to recombinant Sm-p80 produced a wide spectrum of cytokines representing Th1, Th2 and Th17 types, as ascertained via RT-PCR analysis. These findings further strengthen the importance of Sm-p80 molecule as a vaccine candidate for intestinal schistosomiasis.


Subject(s)
Antigens, Helminth/immunology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/prevention & control , Vaccines, DNA/immunology , Animals , Antibodies, Helminth/blood , Antigens, Helminth/genetics , Cell Proliferation , Cytokines/metabolism , Female , Genetic Vectors , Humans , Immunoglobulin A/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Leukocytes, Mononuclear/immunology , Mice , Mice, Inbred C57BL , Schistosoma mansoni/genetics , Schistosomiasis mansoni/immunology , Spleen/immunology , Vaccines, DNA/genetics
12.
Dis Esophagus ; 22(3): 216-22, 2009.
Article in English | MEDLINE | ID: mdl-19207544

ABSTRACT

In patients undergoing chemoradiotherapy for esophageal cancer, the inability to eat may severely impair nutritional status. We conducted a retrospective study to compare the efficacy of the Polyflex self-expanding silicone stent (PS) versus a jejunostomy tube (JT) for maintaining nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer who were scheduled for resectional surgery. Thirty-six patients were treated either with PS placement (12 patients) or JT placement (24 patients) prior to receiving an 8-week course of chemoradiation therapy. Patients were interviewed weekly until cessation of therapy. Patient data were collected on procedural success and complication rates, nutritional status, and dysphagia scores. PS placement was successful in 11 of 12 patients (92%), and those 11 patients were able to resume oral nutrition. Dysphagia scores improved from a mean of 3 to 1 in the PS group (P < 0.005) but did not change significantly in the JT group. PS were removed endoscopically without complications prior to the esophagectomies. Albumin levels and weight increased significantly in both the PS and JT groups. There were no significant differences between groups in the procedural success rates (PS 92% vs. JT 100%, P = 0.33), complication rates (PS 22% vs. JT 4%, P = 0.11), mean increase in weight (PS 4.4 kg vs. JT 4.2 kg, P = 0.59), and mean increase in serum albumin (PS 0.62 g/dL vs. JT 0.44 g/dL, P = 0.05). PS is a safe and effective alternative to a surgical JT for maintaining nutrition in this subset of patients.


Subject(s)
Deglutition Disorders/therapy , Enteral Nutrition , Esophageal Neoplasms/complications , Jejunostomy/instrumentation , Stents , Adenocarcinoma/complications , Adenocarcinoma/therapy , Aged , Aged, 80 and over , Body Weight , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/therapy , Case-Control Studies , Deglutition Disorders/etiology , Endoscopy, Gastrointestinal , Esophageal Neoplasms/therapy , Esophageal Stenosis/etiology , Esophageal Stenosis/therapy , Female , Humans , Laparoscopy , Male , Middle Aged , Neoadjuvant Therapy , Nutritional Status , Retrospective Studies , Serum Albumin/analysis , Severity of Illness Index
13.
Parasite Immunol ; 31(3): 156-61, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19222788

ABSTRACT

No effective vaccine exists for the human parasitic disease, schistosomiasis. We have targeted a functionally important antigen, Sm-p80 as a vaccine candidate because of its consistent immunogenicity, protective potential and important role in the immune evasion process. In this study we report that a Sm-p80-based DNA vaccine formulation confers 59% reduction in worm burden in mice. Animals immunized with Sm-p80-pcDNA3 exhibited a decrease in egg production by 84%. Sm-p80 DNA elicited strong immune responses that include IgG2A and IgG2B antibody isotypes in vaccinated animals. Splenocytes proliferated in response to Sm-p80 produced appreciably more Th1 response enhancing cytokines (IL-2, IFN-gamma) than Th2 response enhancing cytokines (IL-4, IL-10). These data reinforce the potential of Sm-p80 as an excellent vaccine candidate for schistosomiasis.


Subject(s)
Antigens, Helminth/immunology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/prevention & control , Vaccines, DNA/immunology , Animals , Antibodies, Helminth/blood , Antigens, Helminth/genetics , Cell Proliferation , Cytokines/metabolism , Female , Immunoglobulin G/blood , Leukocytes, Mononuclear/immunology , Mice , Mice, Inbred C57BL , Parasite Egg Count , Schistosoma mansoni/genetics , Spleen/immunology , Vaccines, DNA/genetics
14.
J Enzyme Inhib Med Chem ; 24(3): 876-82, 2009 Jun.
Article in English | MEDLINE | ID: mdl-18951282

ABSTRACT

Several substituted phenoxy acetic acid derived pyrazolines were synthesized by the reaction between 2-{4-[3-(2,4-dihydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy} acetic acid and substituted acid hydrazides and were tested for their in vitro cytotoxicity and antiviral activity. None of the compounds showed any specific antiviral activity [50% antivirally effective concentration (EC(50)) > or = 5-fold lower than minimum cytotoxic concentration]. The most cytotoxic of the series was 2-{4-[3-(2,4-dihydroxyphenyl)-1-(2-hydroxybenzoyl-4,5-dihydro-1H-5-pyrazolyl]-2-methoxyphenoxy}acetic acid (3(j)), with a minimum cytotoxic concentration of 0.16 microg/mL in human embryonic lung (HEL) cells.


Subject(s)
Acetates/chemistry , Acetates/pharmacology , Antiviral Agents/chemical synthesis , Antiviral Agents/pharmacology , Pyrazoles/chemistry , Pyrazoles/pharmacology , Acetates/toxicity , Antiviral Agents/chemistry , Antiviral Agents/toxicity , Cell Line , Humans , Lung/cytology , Lung/embryology , Microbial Sensitivity Tests , Pyrazoles/toxicity , Structure-Activity Relationship
15.
Eur J Med Chem ; 43(11): 2331-7, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18031870

ABSTRACT

A series of novel 1-substituted-4-(2-methylphenyl)-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones were synthesized by the cyclization of 2-hydrazino-3-(2-methylphenyl)-3H-quinazolin-4-one with various one carbon donors. The starting material 2-hydrazino-3-(2-methylphenyl)-3H-quinazolin-4-one was synthesized from 2-methyl aniline by a novel innovative route. The title compounds were tested for their in vivo H(1)-antihistaminic activity on guinea pigs; all the tested compounds protected the animals from histamine-induced bronchospasm significantly. Compound 1-methyl-4-(2-methylphenyl)-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-one (II) emerged as the most active compound of the series and it is more potent (72.45%) when compared to the reference standard chlorpheniramine maleate (71%). Compound II showed negligible sedation (11%) when compared to chlorpheniramine maleate (30%). Hence it could serve as the prototype molecule for further development as a new class of H(1)-antihistaminic agents.


Subject(s)
Histamine H1 Antagonists/chemical synthesis , Histamine H1 Antagonists/pharmacology , Quinazolines/chemical synthesis , Quinazolines/pharmacology , Triazoles/chemical synthesis , Triazoles/pharmacology , Animals , Central Nervous System/drug effects , Guinea Pigs , Histamine H1 Antagonists/chemistry , Histamine H1 Antagonists/classification , Male , Methylation , Molecular Structure , Quinazolines/chemistry , Quinazolines/classification , Structure-Activity Relationship , Triazoles/chemistry , Triazoles/classification
16.
Scand J Immunol ; 64(5): 507-14, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17032243

ABSTRACT

Nitration of free and protein associated tyrosine represents, in vivo, a mechanism that can severely compromise the cell function. The detection of 3-nitrotyrosine (3-NT) in pathological tissues is suggestive of the occurrence of nitrating pathways and has been identified as a marker of inflammation and a stable end product of increased reactive nitrogen intermediate production. Protein nitration occurs in many disease conditions including systemic lupus erythematosus (SLE). In this study we show that the level of both free and protein bound 3-NT, which is produced by reactive nitrogen species (RNS)-dependent oxidative damage, is elevated in patients with SLE and that there is a possible role of RNS-modified epitopes in the aetiology of the disease. Commercially available poly L-tyrosine was exposed to nitrating species, inducing nitration in tyrosine residues. Immunoglobulin-G (IgG) purified on Protein-A-Sepharose matrix from 24 SLE patients was studied for their recognition of native and nitrated poly L-tyrosine by direct binding and competition enzyme-linked immunosorbent assay (ELISA). The formation of immune complex between SLE IgG and nitrated poly L-tyrosine was visualized by gel retardation assay. Free 3-NT in patients' sera was detected and quantitated by high performance liquid chromatography whereas protein-bound 3-NT was analysed by Western blotting and the concentration was calculated by sandwich ELISA. The concentration of free 3-NT was found to be 1.4 +/- 0.09 microm whereas the concentration of protein bound 3-NT was 96.52 +/- 21.12 microm nitrated bovine serum albumin equivalents/mg protein, which was significantly higher when compared with healthy controls. Elevated level of 3-NT was observed in SLE patients using two different techniques, when compared with healthy subjects confirms the overproduction of RNS in the pathogenesis of human SLE.


Subject(s)
Immunoglobulin G/metabolism , Lupus Erythematosus, Systemic/blood , Tyrosine/analogs & derivatives , Adolescent , Adult , Autoantibodies/blood , Autoantibodies/metabolism , Blotting, Western , Case-Control Studies , Chromatography, High Pressure Liquid , DNA/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Humans , Lupus Erythematosus, Systemic/immunology , Middle Aged , Protein Binding , Reactive Nitrogen Species/metabolism , Tyrosine/blood
17.
Aliment Pharmacol Ther ; 24(7): 1059-66, 2006 Oct 01.
Article in English | MEDLINE | ID: mdl-16984500

ABSTRACT

BACKGROUND: Laparoscopic cholecystectomy (LC) is recommended for patients with choledocholithiasis after ERCP with sphincterotomy (ES) and stone extraction. AIM: We designed a decision model to address whether ES alone versus ES followed by LC (ES + LC) is the optimal treatment in high-risk patients with choledocholithiasis. METHODS: Our cohort were patients with obstructive jaundice who have undergone an ES with biliary clearance. Recurrent biliary complications over a 2-year period stratified by gallbladder status (in/out) and age-stratified surgical complication rates were obtained from the literature. Failure of therapy was defined as either recurrent symptoms or death attributed to biliary complications. RESULTS: For age 70-79 years, ES failed in 15% whereas ES + LC failed in 17% of cases. Mortality in the EC + LC group was 3.4 times that of the ES alone cohort. For age 80+ years, ES was dominant with an incremental success rate of 8%. Mortality in the ES + LC was 7.6 times that of ES. For age <70, ES + LC was the dominant strategy with an incremental success rate 5%. Sensitivity analysis in the groups confirmed our conclusions. CONCLUSIONS: Management of choledocholithiasis by ES and stone clearance, but without cholecystectomy, should be considered for patients aged 70+. For low-risk patients, ES + LC should be performed to prevent recurrent biliary complications.


Subject(s)
Cholecystectomy/methods , Choledocholithiasis/surgery , Sphincterotomy, Endoscopic/methods , Aged , Aged, 80 and over , Cohort Studies , Decision Support Techniques , Humans , Risk Factors , Survival Rate , Treatment Outcome
18.
Scand J Clin Lab Invest ; 66(5): 429-36, 2006.
Article in English | MEDLINE | ID: mdl-16901852

ABSTRACT

OBJECTIVE: Yield of blood culture in clinically suspected cases of typhoid fever is low, whereas indirect serological diagnostic tests are unreliable. Hence, polymerase chain reaction (PCR)-based detection of Salmonella enterica Serovar typhi was used as an aid for diagnosis of typhoid fever in addition to other diagnostic tests. Two periurban communities in Karachi were selected for an epidemiological study of typhoid fever. The aim of the study was to assess whether PCR increased the detection rate of typhoid fever in children in the community. MATERIAL AND METHODS: Children aged 2 to 14 years presenting with fever lasting for three or more days were selected. PCR using Hashimoto's protocol based on ViaB gene sequence was used in addition to blood culture and other serological tests. RESULTS: Of the 214 children included in the study, blood culture was found positive for S. enterica S. typhi in 26 (12.4%) cases, whereas 24 children (11.7%) were diagnosed as suffering from typhoid fever when the PCR-based method was used. Both tests were positive in only 10 (4.9%) children. The number of children found positive for either test was 40. PCR increased the rate of detection of typhoid fever by 51%. CONCLUSION: The sensitivity, specificity, +ve and -ve predictive values of PCR in this study were 40%, 93%, 45% and 92%, respectively.


Subject(s)
Polymerase Chain Reaction/methods , Salmonella enterica/genetics , Salmonella enterica/isolation & purification , Typhoid Fever/diagnosis , Typhoid Fever/microbiology , Urban Health , Adolescent , Aged , Child , Child, Preschool , Cities , Female , Humans , Male , Middle Aged , Pakistan/epidemiology , Sensitivity and Specificity , Typhoid Fever/blood , Typhoid Fever/epidemiology
19.
J Viral Hepat ; 13(2): 87-95, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16436126

ABSTRACT

Combination therapy with interferon-alpha (IFN-alpha) and ribavirin (RBV) in chronic hepatitis C demonstrates the best responses against hepatitis C virus (HCV) of genotype 3. Still, it has proven to be ineffective in 20-30% of patients infected with this genotype. In the present study, we analysed the translation efficiency mediated by the internal ribosome entry site (IRES) region in HCV genotype 3 genomes isolated from sustained responders (SR) and non-responders (NR), assuming that this may influence the outcome of treatment. Pretreatment isolates of genotype 3 from 22 individuals (15 SR, seven NR) were selected for such analyses. The IRES region [nucleotide (nt) 1-407] was cloned into a dual luciferase vector and IRES activity assessed following transfection into various cell lines. Low relative translation efficiency was observed for IRES elements derived from SR patients, whereas those of NR patients showed significantly greater translation efficiency (29.7 +/- 13 vs 69.4 +/- 22; P < 0.01). Subsequently, the effect of IFN-alpha plus RBV on IRES-driven translation in vitro was determined. A greater suppressive effect was observed on IRES activity isolated from seven SR patients, when compared with seven NR patients. In conclusion, IRES efficiency in vitro correlated with treatment response for HCV genotype 3. Further studies are warranted to investigate whether IRES efficiency in vitro, or sequence motifs associated with IRES efficiency, will be worthwhile to explore as prognostic tools for other HCV genotypes in the treatment of chronic HCV infection.


Subject(s)
Antiviral Agents/therapeutic use , Hepacivirus/genetics , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/virology , Interferon-alpha/therapeutic use , RNA, Viral/genetics , Ribavirin/therapeutic use , Adult , Animals , Base Sequence , Cell Line , Down-Regulation , Drug Therapy, Combination , Hepacivirus/isolation & purification , Humans , Molecular Sequence Data , Nucleic Acid Conformation , Protein Biosynthesis/drug effects , Protein Biosynthesis/physiology , Species Specificity , Treatment Outcome , Viral Proteins/genetics
20.
Acta Neurochir (Wien) ; 148(2): 155-66; discussion 166, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16283103

ABSTRACT

BACKGROUND: Craniocerebral invasive Aspergillosis of sino-nasal origin has been reported with a very high mortality due to a peculiarly fulminant clinical course. Early diagnosis based on clinical radiological imaging may have an impact on final clinical outcome. This retrospective study focuses on characteristic MR imaging features of Aspergillosis (of sinonasal origin) in immunocompetent patients. METHODS: Medical records of patients were reviewed retrospectively during the period from 1991 to 2003 in the two tertiary care hospitals. All the patients had radiological evidence of disease in the paranasal sinuses with or without intracranial extension. Immunocompetence of patients was assessed on clinical and radiological data. MRI scans (n=20) were reviewed by both clinical neurosurgeons and neuroradiologists separately. MRI was done on 1.5 tesla scanners and both T2-weighted and T1 weighted sequences were obtained followed gadolinium enhanced images. Patients were categorized into three types based on their anatomical location on MRI scans; type-1 being intracerebral, type-2 as intracranial extradural and type-3 invading orbit and/or skull base only. All these patient had the epicenter of disease in the nose and/or paranasal sinuses as evident on MR imaging. All patients underwent standard surgical intervention followed by antifungal therapy. Clinical outcome was assessed on Glasgow outcome scale with mean duration of clinical follow up of 13.9 months. FINDINGS: Mean age of patents (n=20) was 31.1 years with male preponderance (3:1). MRI scans showed evidence of disease in paranasal sinuses including mucosal thickening (n=11) and complete filling of sinuses (n=9). T2-weighted images showed extremely hypo-intense fungal mass (n=19) while T1-weighted images had iso-intense signals (n=18). Gadolinium-enhanced images showed bright homogenous contrast enhancement (n=18) and peripheral ring enhancement pattern (n=2). All patients underwent appropriated surgical procedures depending upon anatomical location followed by standard antifungal therapy. Tissue diagnoses were established by histopathology (n=20) and culture growth (n=5). Overall mortality remained 15 percent. INTERPRETATION: Craniocerebral Aspergillosis of sinonasal origin has typical MR imaging features. These features include a mass lesion producing hypo-to-iso-intense signals on T1-weighted, extremely low signals (hypo-intense) on T2-weighted images, with bright homogenous enhancement on post-gadolinium T1-weighted imaging. These features in the clinical background may be helpful in early diagnosis and management of Aspergillosis of sino-nasal origin in immunocompetent hosts. Prospective clinical study is required to make firm clinical therapeutic recommendations.


Subject(s)
Brain/microbiology , Brain/pathology , Meningitis, Fungal/diagnosis , Neuroaspergillosis/diagnosis , Skull Base/microbiology , Skull Base/pathology , Adolescent , Adult , Aged , Antifungal Agents/administration & dosage , Brain/physiopathology , Disease Progression , Female , Humans , Immunocompetence/immunology , Magnetic Resonance Imaging , Male , Meningitis, Fungal/physiopathology , Meningitis, Fungal/therapy , Middle Aged , Nasal Cavity/microbiology , Nasal Cavity/pathology , Nasal Cavity/physiopathology , Neuroaspergillosis/physiopathology , Neuroaspergillosis/therapy , Neurosurgical Procedures , Orbit/microbiology , Orbit/pathology , Orbit/physiopathology , Paranasal Sinus Diseases/complications , Paranasal Sinus Diseases/microbiology , Paranasal Sinus Diseases/physiopathology , Paranasal Sinuses/microbiology , Paranasal Sinuses/pathology , Paranasal Sinuses/physiopathology , Retrospective Studies , Skull Base/physiopathology , Survival Rate , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...